DE69819727D1 - Stabilisierte carbapenem-zwischenprodukteund ihre verwendung in der synthese - Google Patents

Stabilisierte carbapenem-zwischenprodukteund ihre verwendung in der synthese

Info

Publication number
DE69819727D1
DE69819727D1 DE69819727T DE69819727T DE69819727D1 DE 69819727 D1 DE69819727 D1 DE 69819727D1 DE 69819727 T DE69819727 T DE 69819727T DE 69819727 T DE69819727 T DE 69819727T DE 69819727 D1 DE69819727 D1 DE 69819727D1
Authority
DE
Germany
Prior art keywords
synthesis
intermediate products
carbapenem intermediate
formula
stabilized carbapenem
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69819727T
Other languages
English (en)
Other versions
DE69819727T2 (de
Inventor
M Williams
M Brands
T Skerlj
H Dolling
B Jobson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme LLC
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9719383.3A external-priority patent/GB9719383D0/en
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of DE69819727D1 publication Critical patent/DE69819727D1/de
Application granted granted Critical
Publication of DE69819727T2 publication Critical patent/DE69819727T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE69819727T 1997-06-16 1998-06-12 Stabilisierte carbapenem-zwischenprodukteund ihre verwendung in der synthese Expired - Lifetime DE69819727T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US4964097P 1997-06-16 1997-06-16
US49640P 1997-06-16
GBGB9719383.3A GB9719383D0 (en) 1997-09-11 1997-09-11 Stabilized carbapenem intermediates and improved process for carbapenem synthesis
GB9719383 1997-09-11
PCT/US1998/012339 WO1998057973A1 (en) 1997-06-16 1998-06-12 Stabilized carbapenem intermediates and synthetic use

Publications (2)

Publication Number Publication Date
DE69819727D1 true DE69819727D1 (de) 2003-12-18
DE69819727T2 DE69819727T2 (de) 2004-09-23

Family

ID=26312229

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69819727T Expired - Lifetime DE69819727T2 (de) 1997-06-16 1998-06-12 Stabilisierte carbapenem-zwischenprodukteund ihre verwendung in der synthese

Country Status (20)

Country Link
EP (1) EP0991651B1 (de)
JP (1) JP3245427B2 (de)
KR (1) KR100364339B1 (de)
CN (1) CN1105719C (de)
AT (1) ATE254127T1 (de)
AU (1) AU726882B2 (de)
BR (1) BR9810135A (de)
CA (1) CA2293835C (de)
DE (1) DE69819727T2 (de)
DK (1) DK0991651T3 (de)
EA (1) EA001926B1 (de)
ES (1) ES2210773T3 (de)
HU (1) HUP0004243A3 (de)
NZ (1) NZ500955A (de)
PL (1) PL337016A1 (de)
PT (1) PT991651E (de)
SK (1) SK179799A3 (de)
UA (1) UA58469C2 (de)
WO (1) WO1998057973A1 (de)
YU (1) YU65899A (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6548492B1 (en) * 1999-10-29 2003-04-15 Merck & Co., Inc. Process for formulation of carbapenem antibiotic compositions
ATE285770T1 (de) * 1999-10-29 2005-01-15 Merck & Co Inc Verfahren zur herstellung von carbapenem- antibiotika zubereitungen
WO2003016312A1 (fr) * 2001-08-13 2003-02-27 Eisai Co., Ltd. Procede de preparation d'antibiotiques a base de carbapenem
EP1686129A1 (de) * 2004-08-18 2006-08-02 Sandoz AG Carbapenem-Verbindungen, ihre Herstellung und Verwendung in Synthese von Carbapenemen
CN100582106C (zh) * 2006-01-27 2010-01-20 上海医药工业研究院 一种吡咯烷硫基碳青霉烯衍生物的制备方法及其中间体
CN101328179B (zh) * 2007-06-15 2011-01-12 山东轩竹医药科技有限公司 含有氧代氮杂环的巯基吡咯烷培南衍生物
CN101367804B (zh) * 2007-06-26 2010-12-15 山东轩竹医药科技有限公司 含有金刚烷的培南衍生物
CN101362760B (zh) * 2007-08-07 2010-12-15 山东轩竹医药科技有限公司 1β-甲基碳代青霉烯化合物
EP2303225B1 (de) * 2008-06-11 2013-11-20 Ranbaxy Laboratories Limited Zusammensetzungen des Kohlenstoffdioxid Adduktes von Ertapenem und Polymorphe Formen des Mononatriumsalzes von Ertapenem
CN102918041A (zh) * 2010-05-21 2013-02-06 山东轩竹医药科技有限公司 碳青霉烯衍生物或其水合物的晶型及其制备方法与用途
CA2887098A1 (en) 2012-10-12 2014-04-17 Sandoz Ag Preparation of ertapenem intermediates
WO2014085471A1 (en) * 2012-11-28 2014-06-05 Prognosdx Health, Inc. Acid-activated compositions for the treatment of cancers, methods of their use and methods of their preparation
CN103537192A (zh) * 2013-10-25 2014-01-29 上海珺领生化科技有限公司 一种提纯、浓缩厄他培南水溶液的膜集成装置

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9202298D0 (en) * 1992-02-04 1992-03-18 Ici Plc Antibiotic compounds
HRP970281B1 (en) * 1996-05-28 2002-04-30 Merck & Co Inc Carbapenem antibiotic, composition and method of preparation

Also Published As

Publication number Publication date
JP2000511206A (ja) 2000-08-29
EA200000030A1 (ru) 2000-06-26
BR9810135A (pt) 2000-08-08
ATE254127T1 (de) 2003-11-15
CN1105719C (zh) 2003-04-16
AU726882B2 (en) 2000-11-23
UA58469C2 (uk) 2003-08-15
AU8142998A (en) 1999-01-04
EA001926B1 (ru) 2001-10-22
PL337016A1 (en) 2000-07-31
HUP0004243A2 (en) 2001-03-28
CA2293835A1 (en) 1998-12-23
ES2210773T3 (es) 2004-07-01
DE69819727T2 (de) 2004-09-23
HUP0004243A3 (en) 2001-12-28
YU65899A (sh) 2001-05-28
WO1998057973A1 (en) 1998-12-23
JP3245427B2 (ja) 2002-01-15
SK179799A3 (en) 2000-09-12
PT991651E (pt) 2004-03-31
EP0991651A4 (de) 2001-06-13
DK0991651T3 (da) 2004-03-08
EP0991651B1 (de) 2003-11-12
KR100364339B1 (ko) 2002-12-18
EP0991651A1 (de) 2000-04-12
CA2293835C (en) 2003-09-16
KR20010013774A (ko) 2001-02-26
CN1259949A (zh) 2000-07-12
NZ500955A (en) 2001-06-29

Similar Documents

Publication Publication Date Title
ATE254127T1 (de) Stabilisierte carbapenem-zwischenprodukteund ihre verwendung in der synthese
CA2290709A1 (en) 2,6-diaminopyridine compounds as intermediates for producing antibacterial dihydropyridone carboxylic acid derivatives
CA2264824A1 (en) A process for preparing 2-amino malonic acid derivatives and 2-amino-1,3-propanediol derivatives, and intermediates for preparing the same
YU61793A (sh) POSTUPAK ZA DOBIJANJE 5-SUPSTITUISANIH PIROL [2,3-d] PIRIMIDINA
CA2176935A1 (fr) Arylpiperazines derivees d'indole comme ligands pour les recepteurs 5 ht1-like 5 ht1b et 5 ht1d
RS50494B (sr) Poboljšani postupak za sintezu karbapenema
HUT70194A (en) Quinoline- or quinazoline derivatives, process for producing them and pharmaceutical compositions containing them
CA2216633A1 (en) Synthesis of bis-indolylmaleimides
CA2226406A1 (en) Novel pyridone carboxylic acid derivatives
EA199900821A1 (ru) Способ получения производных пиразола
DE69214784D1 (de) Verfahren zur herstellung von cephalosporinzwischenverbindungen
TR200100286T2 (tr) (1H)-Benzo[C]kuinolizin-3-on türevlerinin sentezi için proses.
HUP0100453A1 (hu) Eljárás izokarbamidok előállítására
DK0612310T3 (da) Fremgangsmåde til fremstilling af kanelsyrederivater
EP0987255A3 (de) Substituierte Aminochinazolinon (thion) Derivate
FI974435A (fi) Menetelmä 2,4-diklooripyridiinien muuttamiseksi 2-aryylioksi-4-klooripyridiineiksi
FI961680A (fi) Menetelmä epäsymmetrisesti substituoitujen triatsiinien valmistamiseksi
CA2120164A1 (en) Process for the preparation of aminotriazine derivatives
CA2164152A1 (en) New compounds of the secomacrolide and secoazalide class and a process for the preparation thereof
RU95112573A (ru) Способ получения 9-аминокамптотецина, промежуточные продукты, способ их получения и фармкомпозиция
AU7582396A (en) Synthesis of carboxylic acid derivatives
EP1010695A4 (de) Verfahren zur herstellung von chinazolinderivaten
EP1104424A4 (de) Verfahren zur synthese von carbapenem-zwischenprodukten und hergestellte verbindungen
ATE245647T1 (de) Gegebenenfalls geschützte 3- hydroxymethylcarbapeneme und ihre synthese
DE69432777D1 (de) Verfahren zur synthese von 4-substituierten azetidinon-derivaten

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: MERCK SHARP & DOHME CORP., NEW JERSEY, N.J., US

R081 Change of applicant/patentee

Ref document number: 991651

Country of ref document: EP

Owner name: SCHERING CORPORATION, US

Free format text: FORMER OWNER: MERCK SHARP & DOHME CORP., 07065-0900 RAHWAY, US

Effective date: 20121213

R082 Change of representative

Ref document number: 991651

Country of ref document: EP

Representative=s name: ABITZ & PARTNER, DE

Effective date: 20121213